During the Life Sciences session on the third day of the STB Days 2025, an event organized by the General Consulate of Italy in Boston to highlight Italian and Italian-American excellence in science, technology, and business, Dr. Ilaria Barone, Senior Researcher at Hemera, presented the latest progress of the REMaST® project — the cell therapy developed by our company for nervous tissue regeneration and the treatment of spinal cord injuries.
The presentation took place in the heart of the Boston–Cambridge biotechnology ecosystem, one of the world’s most dynamic hubs for life sciences innovation, where universities, research centers, and companies work together to redefine the future of medicine.
Hemera’s participation in this prestigious international event reflects the company’s ongoing commitment to promoting Italian scientific research on a global scale and to strengthening dialogue with the international biotechnology community.